欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2021, Vol. 21 ›› Issue (02): 233-238.DOI: 10.3969/j.issn.1009-976X.2021.02.022

• 综述 • 上一篇    下一篇

基于增强CT的影像组学模型对BCLC B期肝细胞癌治疗方式选择的研究进展

胡志鹏1,2, 孙强1,2, 胡泽民1,2, 陈伟强1,2,*   

  1. 1.广东医科大学研究生学院,广东湛江 524002;
    2.中山大学附属中山医院/中山市人民医院普外一科,广东中山528400
  • 通讯作者: *陈伟强,主任医师,硕士研究生导师,Email: cwq20138@aliyun.com
  • 基金资助:
    中山市科技计划项目(2017B1055)

Advances in the selection of therapeutic modalities for BCLC stage-B hepatocellular carcinoma based on enhanced CT radiomics model

HU Zhi-peng1,2, SUN Qiang1,2, HU Ze-min1,2, CHEN Wei-qiang1,2   

  1. 1. Graduate School of Guangdong Medical University, Zhanjiang, Guangdong 524002, China;
    2. Zhongshan Hospital Affiliated to Sun Yat-sen University/Zhongshan People-s Hospital, Zhongshan, Guangdong 528400, China
  • Received:2020-10-30 Online:2021-04-20 Published:2021-06-18
  • Contact: CHEN Wei-qiang, cwq20138@aliyun.com

摘要: 影像组学是一个新兴的领域,通过从不同的医疗图像中挖掘高通量的特征数据筛选能够反映肝癌异质性的标记物并建立相应的模型有助于BCLC B期(中期)肝癌的风险分层、治疗反应评估、预后预测,有助于辅助临床决策,为BCLC B期肝癌患者提供个体化治疗方案,提高生存率和治愈率。本文通过对BCLC B期肝癌的管理策略、影像组学在肝癌中的应用进行综述,进一步探讨了基于增强CT的影像组学模型在对BCLC B期肝细胞癌治疗方式选择中的巨大潜力。

关键词: 影像组学, BCLC B期肝细胞癌, 中期肝癌, 风险分层, 治疗选择

Abstract: Radiomics is a new field by mining high-throughput characteristic data from different medical images, screening potential markers that can reflect the heterogeneity of hepatocellular carcinoma and establishing corresponding models are helpful to the risk stratification,treatment response evaluation and prognosis prediction of BCLC stage-B (intermediate-stage) hepatocellular carcinoma,assist clinical decision-making, provide individualized treatment for patients with BCLC stage-B hepatocellular carcinoma, improve the survival rate and cure rate. This paper reviews the management strategy of BCLC stage-B hepatocellular carcinoma and the application of radiomics in hepatocellular carcinoma, then further discusses the great potential of radiomics model based on enhanced CT in the choice of treatment for BCLC stage-B hepatocellular carcinoma.

Key words: radiomics, BCLC stage-B hepatocellular carcinoma, intermediate-stage hepatocellular carcinoma, risk stratification, selection of therapeutic modalities

中图分类号: